Guardant Health, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
133.6M
on 2026-06-30, from 121.8M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
No limit
S-3ASR of 2026-07-30. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-07-30 is not read yet.
Cash
22.8 quarters
$1.05B on 2026-06-30 ÷ $46.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-11-06 | Public offering | 3,333,333 | $90.00 | $300.0M | 424B5 ↗ |
Also on file: $1K convertible notes, 2025-02-06 8-K ↗ · $1K convertible notes, 2025-02-14 8-K ↗ · $52.5M convertible notes, 2025-11-04 8-K ↗